United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - empagliflozin; metformin hydrochloride - tablet - 5mg ; 850mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - metformin hydrochloride; empagliflozin - tablet - 1gram ; 5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - metformin hydrochloride; empagliflozin - tablet - 850mg ; 12.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - empagliflozin; metformin hydrochloride - tablet - 12.5mg ; 1gram

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim - empagliflozin, metformin - diabetes mellitus, type 2 - drugs used in diabetes - synjardy is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients inadequately controlled on their maximally tolerated dose of metformin alone;in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin;in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - empagliflozin; metformin hydrochloride - tablet - 5mg; 500mg - empagliflozin 5mg; metformin hydrochloride 500mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - empagliflozin; metformin hydrochloride - tablet - 5mg; 850mg - empagliflozin 5mg; metformin hydrochloride 850mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - empagliflozin; metformin hydrochloride - tablet - 5mg; 1000mg - empagliflozin 5mg; metformin hydrochloride 1000mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - empagliflozin; metformin hydrochloride - tablet - 12.5mg; 500mg - empagliflozin 12.5mg; metformin hydrochloride 500mg - sodium-glucose cotransporter 2 (sglt2) inhibitors

Canada - English - Health Canada

boehringer ingelheim (canada) ltd ltee - empagliflozin; metformin hydrochloride - tablet - 12.5mg; 850mg - empagliflozin 12.5mg; metformin hydrochloride 850mg - sodium-glucose cotransporter 2 (sglt2) inhibitors